Add to ORKG[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=1932-6203&DestApp=JCR&RQ=IF_CAT_BOXPLOT[[note]]http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=RID&SrcApp=RID&DestLinkType=FullRecord&DestApp=ALL_WOS&KeyUT=00030640670000
Identification of hepatocellular carcinoma-associated tumor antigens is necessary and pivotal for sp...
[[sponsorship]]基因體研究中心[[note]]已出版;沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gatewa...
[[sponsorship]]基因體研究中心[[note]]已出版;沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gatewa...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];沒有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/G...
<div><p>Hepatocellular carcinoma (HCC) is one of the most common human malignancies. Therefore, deve...
[[abstract]]Hepatocellular carcinoma (HCC) is one of the most common human malignancies. Therefore, ...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
既往肿瘤免疫治疗虽经历临床长期尝试,但因肿瘤抗原不明确,疗效不稳定,而受到怀疑 . 20世纪90年代初,用细胞免疫学方法,鉴定并克隆出肿瘤抗原编码基因[1],无可置疑地证明了肿瘤特异抗原(tumor-...
To identify tumour and tumour-associated antigens in patients with hepatocellular carcinoma (HCC) on...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
Hepatocellular carcinoma (HCC) is a common cancer in the world due to high prevalence of hepatitis B...
[[sponsorship]]資訊科學研究所,資訊科技創新研究中心[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com...
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAM...
Hepatocellular carcinoma (HCC) exerts huge effects on the health burden of the world because of its ...
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. Inter...
Identification of hepatocellular carcinoma-associated tumor antigens is necessary and pivotal for sp...
[[sponsorship]]基因體研究中心[[note]]已出版;沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gatewa...
[[sponsorship]]基因體研究中心[[note]]已出版;沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gatewa...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];沒有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/G...
<div><p>Hepatocellular carcinoma (HCC) is one of the most common human malignancies. Therefore, deve...
[[abstract]]Hepatocellular carcinoma (HCC) is one of the most common human malignancies. Therefore, ...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
既往肿瘤免疫治疗虽经历临床长期尝试,但因肿瘤抗原不明确,疗效不稳定,而受到怀疑 . 20世纪90年代初,用细胞免疫学方法,鉴定并克隆出肿瘤抗原编码基因[1],无可置疑地证明了肿瘤特异抗原(tumor-...
To identify tumour and tumour-associated antigens in patients with hepatocellular carcinoma (HCC) on...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
Hepatocellular carcinoma (HCC) is a common cancer in the world due to high prevalence of hepatitis B...
[[sponsorship]]資訊科學研究所,資訊科技創新研究中心[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com...
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAM...
Hepatocellular carcinoma (HCC) exerts huge effects on the health burden of the world because of its ...
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. Inter...
Identification of hepatocellular carcinoma-associated tumor antigens is necessary and pivotal for sp...
[[sponsorship]]基因體研究中心[[note]]已出版;沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gatewa...
[[sponsorship]]基因體研究中心[[note]]已出版;沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gatewa...